SCHEMBL6003087

SCHEMBL6003087

CCCCC(Cl)(C(=O)O)C(Cl)(CCCC)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FDPS P14324 1/20 0.41
ALDH1A1 P00352 3/20 0.39
AKR1B1 P15121 1/20 0.39
TP53 P04637 1/20 0.39
GPR84 Q9NQS5 7/20 0.37
PPARG P37231 6/20 0.37
PPARD Q03181 6/20 0.37
PPARA Q07869 6/20 0.37
HDAC11 Q96DB2 5/20 0.37
TSHR P16473 4/20 0.37
TLR2 O60603 2/20 0.37
TDP1 Q9NUW8 2/20 0.37
FABP4 P15090 2/20 0.37
PTPN1 P18031 2/20 0.37
SLC22A6 Q4U2R8 1/20 0.37
SLC22A8 Q8TCC7 1/20 0.37
MEN1 O00255 1/20 0.37
ESR1 P03372 1/20 0.37
ALOX15 P16050 1/20 0.37
PDE4A P27815 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6003007 0.93 FDPS (0.43) FDPSALDH1A1AKR1B1GPR84PPARG
SCHEMBL6002240 0.91 SMPD1 (0.45) FDPSALDH1A1GPR84PPARGPPARD
SCHEMBL6003507 0.84 ALDH1A1 (0.40) FDPSALDH1A1TP53TSHRTDP1
SCHEMBL1158403 0.80 FDPS (0.41) FDPSALDH1A1AKR1B1TP53GPR84
SCHEMBL607576 0.78 FDPS (0.40) FDPSALDH1A1AKR1B1TP53GPR84
SCHEMBL607577 0.78 FDPS (0.40) FDPSALDH1A1AKR1B1TP53GPR84
SCHEMBL9243044 0.76 FDPS (0.39) FDPSALDH1A1AKR1B1TP53GPR84
SCHEMBL1707379 0.76 CES2 (0.41) FDPSAKR1B1MEN1KMT2AHSD17B10
SCHEMBL30507708 0.75 FDPS (0.42) FDPSALDH1A1AKR1B1TP53GPR84
SCHEMBL476932 0.74 AKR1B1 (0.42) FDPSALDH1A1AKR1B1GPR84PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060217565-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217565-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL FDPS 882/4885ALDH1A1 3157/4885AKR1B1 237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.